News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
186 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27903)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Aytu BioScience Provides Update on the Continued Growth of Natesto in the U.S.
Significant Natesto prescription growth continued through October 2017, with prescriptions increasing 17% from the previous month, reaching their highest levels to date.
November 28, 2017
·
5 min read
Biotech Beach
Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept’s Liquid Biopsy Test in Immunotherapy
The 100-patient study is designed to clinically validate Biocept’s Target Selector PD-L1 assay for patients diagnosed with NSCLC.
November 28, 2017
·
5 min read
Business
Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017
The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST).
November 28, 2017
·
1 min read
Business
Varian Partners With Penn Medicine for Proton Therapy Training and Education Program
The program will cover all aspects of proton therapy, from patient selection and planning through treatment and follow-up.
November 28, 2017
·
1 min read
Business
X-Chem and Gilead Announce Drug Discovery Collaboration
Agreement leverages X-Chem’s DEX DNA-Encoded Libraries and Gilead’s proprietary know-how to enable the discovery of new chemical entities.
November 28, 2017
·
3 min read
Biotech Beach
Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner
The power of dedicated research, and discovery of new gene mutation variants help develop much-needed treatments.
November 28, 2017
·
3 min read
Business
Charles River Announces Success of Integrated Discovery Project With ENYO Pharma
ENYO Pharma worked with scientists from Charles River to optimize a potent, novel chemical series (with unknown molecular target) for inhibition of Influenza replication.
November 28, 2017
·
4 min read
Drug Development
Enrollment Completed in Flex Pharma’s Phase II Exploratory Spasticity Study in MS
The randomized, placebo-controlled, blinded, cross-over study is designed to evaluate the safety and efficacy of FLX-787.
November 28, 2017
·
5 min read
Business
Ironwood Appoints New COO and CFO
The company announced the appointment of William Huyett as COO and the promotion of Gina Consylman to senior vice president and CFO.
November 28, 2017
·
6 min read
Bio NC
IQVIA Announces Pricing of Secondary Public Offering
The Repurchase will be completed outside IQVIA’s existing share repurchase program, under which IQVIA has approximately $195 million of remaining availability.
November 28, 2017
·
3 min read
Previous
5 of 19
Next